<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[GSK begynder at eksevere på sin nye opkøbsstrategi.]]></title><description><![CDATA[<p dir="auto">Og inden I får glade tanker om et andet Biotekselskab, så er der effektivt lukket af for den slags med Janssens overtagelse af 10,7% af Genmab</p>
<p dir="auto"><a href="http://www.gsk.com/media/press-releases/2012/GSK-announces-agreement-in-principle-to-increase-its-stake-in-GlaxoSmithKline-Consumer-Nigeria-PLC.html" rel="nofollow ugc">http://www.gsk.com/media/press-releases/2012/GSK-announces-agreement-in-principle-to-increase-its-stake-in-GlaxoSmithKline-Consumer-Nigeria-PLC.html</a></p>
<p dir="auto"><a href="http://www.gsk.com/media/press-releases/2012/GSK-initiates-voluntary-open-offer-Consumer-Healthcare-subsidiary-India.html" rel="nofollow ugc">http://www.gsk.com/media/press-releases/2012/GSK-initiates-voluntary-open-offer-Consumer-Healthcare-subsidiary-India.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/436917/gsk-begynder-at-eksevere-p-sin-nye-opkbsstrategi</link><generator>RSS for Node</generator><lastBuildDate>Mon, 27 Jul 2026 18:49:39 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/436917.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 26 Nov 2012 08:27:29 GMT</pubDate><ttl>60</ttl></channel></rss>